 Steven Ojemann
Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deep Brain Stimulation | 19 | 2024 | 125 | 3.320 |
Why?
| | Parkinson Disease | 17 | 2024 | 461 | 2.780 |
Why?
| | Subthalamic Nucleus | 11 | 2024 | 67 | 1.960 |
Why?
| | Dystonic Disorders | 2 | 2021 | 24 | 0.920 |
Why?
| | Essential Tremor | 2 | 2021 | 14 | 0.900 |
Why?
| | Drug Resistant Epilepsy | 5 | 2024 | 82 | 0.810 |
Why?
| | Intralaminar Thalamic Nuclei | 1 | 2022 | 13 | 0.770 |
Why?
| | Obsessive-Compulsive Disorder | 1 | 2021 | 44 | 0.710 |
Why?
| | Epilepsy | 4 | 2025 | 322 | 0.530 |
Why?
| | Laser Therapy | 4 | 2021 | 131 | 0.530 |
Why?
| | Stereotaxic Techniques | 3 | 2024 | 37 | 0.480 |
Why?
| | Electrodes, Implanted | 3 | 2020 | 106 | 0.390 |
Why?
| | Globus Pallidus | 3 | 2021 | 23 | 0.360 |
Why?
| | Thalamus | 3 | 2021 | 100 | 0.350 |
Why?
| | Seizures | 5 | 2025 | 401 | 0.340 |
Why?
| | Silicones | 1 | 2010 | 22 | 0.340 |
Why?
| | Facial Pain | 1 | 2010 | 13 | 0.340 |
Why?
| | Vagus Nerve Stimulation | 1 | 2010 | 30 | 0.330 |
Why?
| | Putamen | 2 | 2020 | 22 | 0.310 |
Why?
| | Beta Rhythm | 2 | 2024 | 19 | 0.280 |
Why?
| | Epilepsy, Temporal Lobe | 2 | 2017 | 33 | 0.270 |
Why?
| | Encephalitis, Herpes Simplex | 1 | 2005 | 21 | 0.240 |
Why?
| | Electrocorticography | 1 | 2025 | 15 | 0.240 |
Why?
| | Anterior Thalamic Nuclei | 1 | 2024 | 4 | 0.230 |
Why?
| | Treatment Outcome | 12 | 2023 | 10202 | 0.220 |
Why?
| | Glutamate Decarboxylase | 2 | 2017 | 166 | 0.220 |
Why?
| | Neurosurgical Procedures | 2 | 2024 | 166 | 0.220 |
Why?
| | Medical Errors | 1 | 2024 | 103 | 0.210 |
Why?
| | Humans | 41 | 2025 | 129266 | 0.210 |
Why?
| | Brain Mapping | 3 | 2003 | 574 | 0.210 |
Why?
| | Intracranial Aneurysm | 1 | 2023 | 95 | 0.200 |
Why?
| | Cerebral Cortex | 2 | 2003 | 436 | 0.200 |
Why?
| | Genetic Therapy | 2 | 2017 | 288 | 0.200 |
Why?
| | Pars Reticulata | 1 | 2022 | 6 | 0.190 |
Why?
| | Methylphenidate | 1 | 2022 | 36 | 0.190 |
Why?
| | Middle Aged | 17 | 2025 | 31090 | 0.190 |
Why?
| | Psychosurgery | 1 | 2021 | 8 | 0.190 |
Why?
| | Zona Incerta | 1 | 2021 | 3 | 0.180 |
Why?
| | Caudate Nucleus | 1 | 2020 | 20 | 0.170 |
Why?
| | Meningioma | 2 | 2000 | 81 | 0.170 |
Why?
| | Anticoagulants | 1 | 2005 | 636 | 0.170 |
Why?
| | Meningeal Neoplasms | 2 | 2000 | 92 | 0.170 |
Why?
| | Language | 1 | 2003 | 283 | 0.170 |
Why?
| | Health Literacy | 1 | 2022 | 159 | 0.160 |
Why?
| | Robotic Surgical Procedures | 1 | 2021 | 114 | 0.160 |
Why?
| | Surgery, Computer-Assisted | 2 | 2017 | 76 | 0.160 |
Why?
| | Evoked Potentials, Auditory | 1 | 2020 | 179 | 0.150 |
Why?
| | Corpus Striatum | 1 | 2020 | 159 | 0.150 |
Why?
| | Aged | 11 | 2024 | 22032 | 0.140 |
Why?
| | Psychotic Disorders | 1 | 2020 | 151 | 0.140 |
Why?
| | Radiosurgery | 1 | 2000 | 320 | 0.140 |
Why?
| | Brain | 3 | 2025 | 2669 | 0.140 |
Why?
| | Transcriptome | 1 | 2023 | 874 | 0.140 |
Why?
| | Male | 20 | 2025 | 63512 | 0.140 |
Why?
| | Diffusion Tensor Imaging | 1 | 2017 | 76 | 0.130 |
Why?
| | Magnetic Resonance Imaging | 9 | 2021 | 3386 | 0.130 |
Why?
| | Retrospective Studies | 7 | 2023 | 14461 | 0.130 |
Why?
| | Suicide | 1 | 2023 | 580 | 0.130 |
Why?
| | Female | 18 | 2025 | 68551 | 0.130 |
Why?
| | Databases, Factual | 1 | 2021 | 1266 | 0.120 |
Why?
| | Vision Disorders | 1 | 2017 | 135 | 0.120 |
Why?
| | Amygdala | 1 | 2017 | 198 | 0.120 |
Why?
| | Gene Transfer Techniques | 2 | 2017 | 161 | 0.110 |
Why?
| | Depressive Disorder | 1 | 2017 | 366 | 0.110 |
Why?
| | Adult | 14 | 2025 | 35495 | 0.100 |
Why?
| | Hippocampus | 1 | 2017 | 871 | 0.090 |
Why?
| | Microelectrodes | 2 | 2024 | 43 | 0.090 |
Why?
| | Motor Cortex | 2 | 2003 | 58 | 0.090 |
Why?
| | Phrenic Nerve | 1 | 2010 | 6 | 0.090 |
Why?
| | Quality of Life | 1 | 2022 | 2687 | 0.090 |
Why?
| | Retreatment | 1 | 2010 | 70 | 0.080 |
Why?
| | Speech Disorders | 1 | 2010 | 34 | 0.080 |
Why?
| | Diaphragm | 1 | 2010 | 42 | 0.080 |
Why?
| | Electric Conductivity | 1 | 2010 | 94 | 0.080 |
Why?
| | Equipment Failure | 1 | 2010 | 105 | 0.080 |
Why?
| | Frontal Lobe | 2 | 2003 | 153 | 0.080 |
Why?
| | United States | 2 | 2021 | 13826 | 0.070 |
Why?
| | Follow-Up Studies | 4 | 2017 | 4887 | 0.070 |
Why?
| | Electric Stimulation | 3 | 2003 | 269 | 0.070 |
Why?
| | Brain Neoplasms | 4 | 2003 | 1143 | 0.060 |
Why?
| | Hemangiosarcoma | 1 | 2006 | 20 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2023 | 3377 | 0.060 |
Why?
| | Neuropsychological Tests | 2 | 2022 | 1014 | 0.060 |
Why?
| | Wakefulness | 2 | 2022 | 120 | 0.060 |
Why?
| | Craniotomy | 1 | 2005 | 67 | 0.060 |
Why?
| | Intracranial Hemorrhages | 1 | 2005 | 78 | 0.060 |
Why?
| | Temporal Lobe | 1 | 2005 | 86 | 0.060 |
Why?
| | Vena Cava Filters | 1 | 2005 | 60 | 0.060 |
Why?
| | Neurons | 2 | 2024 | 1494 | 0.060 |
Why?
| | Accidents, Traffic | 1 | 2005 | 184 | 0.050 |
Why?
| | Circle of Willis | 1 | 2023 | 7 | 0.050 |
Why?
| | Middle Cerebral Artery | 1 | 2023 | 43 | 0.050 |
Why?
| | Bone Neoplasms | 1 | 2006 | 231 | 0.050 |
Why?
| | Intraoperative Care | 1 | 2003 | 46 | 0.050 |
Why?
| | Temporal Arteries | 1 | 2023 | 45 | 0.050 |
Why?
| | Basal Ganglia | 1 | 2023 | 53 | 0.050 |
Why?
| | Tremor | 1 | 2023 | 60 | 0.050 |
Why?
| | Pulmonary Embolism | 1 | 2005 | 211 | 0.050 |
Why?
| | Electroencephalography | 1 | 2025 | 399 | 0.050 |
Why?
| | Proof of Concept Study | 1 | 2022 | 69 | 0.050 |
Why?
| | Hypokinesia | 1 | 2022 | 8 | 0.050 |
Why?
| | Epilepsy, Complex Partial | 1 | 2001 | 2 | 0.050 |
Why?
| | Epilepsia Partialis Continua | 1 | 2001 | 4 | 0.050 |
Why?
| | Epilepsy, Tonic-Clonic | 1 | 2001 | 4 | 0.050 |
Why?
| | Neurocytoma | 1 | 2001 | 1 | 0.050 |
Why?
| | Basal Ganglia Cerebrovascular Disease | 1 | 2001 | 3 | 0.050 |
Why?
| | Hemiplegia | 1 | 2001 | 21 | 0.050 |
Why?
| | Substantia Nigra | 1 | 2022 | 56 | 0.050 |
Why?
| | Dominance, Cerebral | 1 | 2001 | 54 | 0.050 |
Why?
| | Upper Extremity | 1 | 2022 | 95 | 0.050 |
Why?
| | Neural Pathways | 2 | 2020 | 302 | 0.050 |
Why?
| | Corpus Callosum | 1 | 2021 | 66 | 0.050 |
Why?
| | Preoperative Care | 1 | 2003 | 339 | 0.040 |
Why?
| | Subarachnoid Hemorrhage | 1 | 2001 | 64 | 0.040 |
Why?
| | Adolescent | 4 | 2025 | 20313 | 0.040 |
Why?
| | Action Potentials | 1 | 2024 | 485 | 0.040 |
Why?
| | Electric Impedance | 1 | 2020 | 102 | 0.040 |
Why?
| | Internal Capsule | 1 | 1999 | 1 | 0.040 |
Why?
| | Supratentorial Neoplasms | 1 | 1999 | 16 | 0.040 |
Why?
| | Atrophy | 1 | 2020 | 171 | 0.040 |
Why?
| | Monitoring, Intraoperative | 1 | 1999 | 47 | 0.040 |
Why?
| | Double-Blind Method | 2 | 2017 | 1875 | 0.040 |
Why?
| | Biomechanical Phenomena | 1 | 2022 | 757 | 0.040 |
Why?
| | Disease-Free Survival | 1 | 2000 | 645 | 0.040 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 1999 | 144 | 0.040 |
Why?
| | Young Adult | 2 | 2025 | 12391 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 2 | 2005 | 2515 | 0.040 |
Why?
| | Pilot Projects | 1 | 2023 | 1584 | 0.040 |
Why?
| | Electromyography | 1 | 1999 | 381 | 0.040 |
Why?
| | Parvovirinae | 1 | 2017 | 2 | 0.030 |
Why?
| | Visual Pathways | 1 | 2017 | 50 | 0.030 |
Why?
| | Visual Fields | 1 | 2017 | 87 | 0.030 |
Why?
| | Dependovirus | 1 | 2017 | 62 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2022 | 727 | 0.030 |
Why?
| | Survival Rate | 1 | 2000 | 1869 | 0.030 |
Why?
| | Life Change Events | 1 | 2017 | 148 | 0.030 |
Why?
| | Positron-Emission Tomography | 1 | 2017 | 286 | 0.030 |
Why?
| | Visual Cortex | 1 | 1995 | 68 | 0.030 |
Why?
| | Anxiety | 1 | 2022 | 962 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2000 | 958 | 0.030 |
Why?
| | Biomarkers | 1 | 2025 | 3968 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3080 | 0.030 |
Why?
| | Aging | 1 | 2003 | 1774 | 0.030 |
Why?
| | Postoperative Complications | 2 | 2001 | 2473 | 0.020 |
Why?
| | Palliative Care | 1 | 2017 | 706 | 0.020 |
Why?
| | Time Factors | 1 | 2020 | 6543 | 0.020 |
Why?
| | Disease Progression | 1 | 2017 | 2630 | 0.020 |
Why?
| | Prospective Studies | 1 | 2021 | 7123 | 0.020 |
Why?
| | Hematoma, Epidural, Spinal | 1 | 2006 | 3 | 0.020 |
Why?
| | Ifosfamide | 1 | 2006 | 34 | 0.020 |
Why?
| | Hemorrhagic Disorders | 1 | 2006 | 8 | 0.020 |
Why?
| | Laminectomy | 1 | 2006 | 29 | 0.020 |
Why?
| | Child | 2 | 2003 | 20785 | 0.020 |
Why?
| | Hemostasis | 1 | 2006 | 79 | 0.020 |
Why?
| | Sacrum | 1 | 2006 | 74 | 0.020 |
Why?
| | Doxorubicin | 1 | 2006 | 328 | 0.010 |
Why?
| | Embolization, Therapeutic | 1 | 2006 | 206 | 0.010 |
Why?
| | Blood Transfusion | 1 | 2006 | 295 | 0.010 |
Why?
| | Magnetoencephalography | 1 | 2003 | 128 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 2006 | 1199 | 0.010 |
Why?
| | Speech | 1 | 2003 | 74 | 0.010 |
Why?
| | Functional Laterality | 1 | 2003 | 222 | 0.010 |
Why?
| | Cerebral Ventricles | 1 | 2001 | 50 | 0.010 |
Why?
| | Electrocoagulation | 1 | 2001 | 37 | 0.010 |
Why?
| | Aneurysm, Ruptured | 1 | 2001 | 34 | 0.010 |
Why?
| | Cerebral Angiography | 1 | 2001 | 108 | 0.010 |
Why?
| | Animals | 1 | 2022 | 35309 | 0.010 |
Why?
| | Glioma | 1 | 2003 | 347 | 0.010 |
Why?
| | Hand | 1 | 1999 | 155 | 0.010 |
Why?
| | Isometric Contraction | 1 | 1999 | 187 | 0.010 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2006 | 1556 | 0.010 |
Why?
| | Child, Preschool | 2 | 2001 | 10459 | 0.010 |
Why?
| | Planning Techniques | 1 | 1995 | 16 | 0.010 |
Why?
| | Tomography, Emission-Computed | 1 | 1995 | 66 | 0.010 |
Why?
| | Neurosurgery | 1 | 1995 | 35 | 0.010 |
Why?
| | Astrocytoma | 1 | 1995 | 115 | 0.010 |
Why?
| | Photic Stimulation | 1 | 1995 | 240 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 1999 | 1613 | 0.010 |
Why?
| | Infant | 1 | 1999 | 8975 | 0.000 |
Why?
|
|
Ojemann's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|